LSD-Perceptual-Choice-Study

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 26, 2024

Primary Completion Date

February 25, 2025

Study Completion Date

February 25, 2025

Conditions
LSD Reaction
Interventions
DRUG

LSD 10 μg

0.5 h after the start of each study session the participants will be administered 10 μg LSD per os in the form of vials containing 1ml 20% EtOH (ethanol).

DRUG

LSD 20 μg

0.5 h after the start of each study session the participants will be administered 20 μg LSD per os in the form of vials containing 1ml 20% EtOH.

DRUG

Placebo

0.5 h after the start of each study session the participants will be administered placebo per os in the form of vials containing 1ml 20% EtOH.

Trial Locations (1)

4002

University Psychiatric Clinics Basel, Basel

All Listed Sponsors
collaborator

University of Basel

OTHER

collaborator

University Psychiatric Clinics Basel

NETWORK

lead

University Hospital, Basel, Switzerland

OTHER

NCT05976698 - LSD-Perceptual-Choice-Study | Biotech Hunter | Biotech Hunter